Annual CFO
-$3.53 M
NaN%
December 1, 2023
Summary
- As of February 9, 2025, CVKD annual cash flow from operations is -$3.53 million
- CVKD annual CFO is now at all-time high.
Performance
CVKD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.20 M
-$672.00 K-43.94%
September 1, 2024
Summary
- As of February 9, 2025, CVKD quarterly cash flow from operations is -$2.20 million, with the most recent change of -$672.00 thousand (-43.94%) on September 1, 2024.
- Over the past year, CVKD quarterly CFO has stayed the same.
- CVKD quarterly CFO is now -4937.07% below its all-time high of -$43.70 thousand, reached on March 31, 2022.
Performance
CVKD Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$6.26 M
-$1.57 M-33.56%
September 1, 2024
Summary
- As of February 9, 2025, CVKD TTM cash flow from operations is -$6.26 million, with the most recent change of -$1.57 million (-33.56%) on September 1, 2024.
- Over the past year, CVKD TTM CFO has stayed the same.
- CVKD TTM CFO is now -14227.69% below its all-time high of -$43.70 thousand, reached on March 31, 2022.
Performance
CVKD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CVKD Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | 0.0% | 0.0% |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
CVKD Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | at low | -4937.1% | at low | <-9999.0% | at low |
5 y | 5-year | at high | at low | -4937.1% | at low | <-9999.0% | at low |
alltime | all time | at high | at low | -4937.1% | at low | <-9999.0% | at low |
Cadrenal Therapeutics Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$2.20 M(+43.9%) | -$6.26 M(+33.6%) |
Jun 2024 | - | -$1.53 M(-16.7%) | -$4.69 M(+18.6%) |
Mar 2024 | - | -$1.84 M(+164.5%) | -$3.95 M(+12.0%) |
Dec 2023 | -$3.53 M | -$694.40 K(+10.6%) | -$3.53 M(+24.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2023 | - | -$627.80 K(-21.1%) | -$2.84 M(+28.4%) |
Jun 2023 | - | -$795.30 K(-43.7%) | -$2.21 M(+56.3%) |
Mar 2023 | - | -$1.41 M(+3133.0%) | -$1.41 M(+3133.0%) |
Mar 2022 | - | -$43.70 K | -$43.70 K |
FAQ
- What is Cadrenal Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics quarterly CFO year-on-year change?
- What is Cadrenal Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics TTM CFO year-on-year change?
What is Cadrenal Therapeutics annual cash flow from operations?
The current annual CFO of CVKD is -$3.53 M
What is the all time high annual CFO for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high annual cash flow from operations is -$3.53 M
What is Cadrenal Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CVKD is -$2.20 M
What is the all time high quarterly CFO for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high quarterly cash flow from operations is -$43.70 K
What is Cadrenal Therapeutics quarterly CFO year-on-year change?
Over the past year, CVKD quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Cadrenal Therapeutics TTM cash flow from operations?
The current TTM CFO of CVKD is -$6.26 M
What is the all time high TTM CFO for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high TTM cash flow from operations is -$43.70 K
What is Cadrenal Therapeutics TTM CFO year-on-year change?
Over the past year, CVKD TTM cash flow from operations has changed by $0.00 (0.00%)